News from lumiradx A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 21, 2021, 11:45 ET LumiraDx recebe autorização para teste de antígeno SARS-CoV-2 no Japão e no Brasil; Itália recomenda expansão de testes de antígeno microfluídico

LumiraDx, a empresa de teste de diagnóstico de ponto de atendimento de última geração, anunciou hoje que recebeu aprovações multinacionais de seu...


Jan 21, 2021, 03:00 ET LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing

LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With...


Jan 13, 2021, 03:00 ET SKUP Reports Positive Evaluation of the LumiraDx SARS-CoV-2 Antigen Test in Symptomatic and Asymptomatic Patients

LumiraDx, the next generation point-of-care diagnostic company, announced today that the Scandinavian evaluation of laboratory equipment for point of ...


Nov 10, 2020, 03:00 ET Global Partnership to Introduce a Connected, Point-of-Care Diagnostic Platform for COVID-19 Antigen Testing in Africa

LumiraDx, the next generation point-of-care diagnostic company, announced today a $32 million global partnership with Africa Union, Africa Centres...


Aug 20, 2020, 14:24 ET LumiraDx recibe la autorización para uso de emergencia de la FDA para su test de antígenos de COVID-19 en punto de atención

LumiraDx, la compañía de diagnósticos en el punto de atención de próxima generación, anunció hoy que ha recibido una Autorización de Uso de...


Aug 20, 2020, 10:59 ET LumiraDx recebe autorização de uso de emergência da FDA para teste de antígeno para a COVID-19 em ponto de cuidado

A LumiraDx, a empresa de diagnóstico em ponto de cuidado da próxima geração, anunciou hoje que recebeu autorização de uso de emergência (AUE) da...


Aug 20, 2020, 06:00 ET LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test

LumiraDx, the next-generation point of care diagnostic company, announced today that it has received Emergency Use Authorization (EUA) from the U.S....